Approval · Notice of Compliance 2939 · 1998
RAXAR: Notice of Compliance 2939
Issued April 9, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2939
- Date
- April 9, 1998
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAXAR | 02237735 | Cancelled Post Market |
Medicinal ingredients
- GREPAFLOXACIN HYDROCHLORIDE 200 MG per TAB